Media Coverage

With COVID-19 cases increasing in 46 states, 10 of which broke single-day records for new cases on Thursday, America has officially entered what experts refer to as the “exponential” phase of spread — a rapid multiplying of cases that can’t be contained through traditional measures. On Thursday alone, the U.S. saw 160,000 new cases of the virus, more than any day since the pandemic began.

Joe Biden will be the 46th president and that the Democrats have held onto the House. With the Election Day dust now settled, let’s take a look at the winners and losers, courtesy of the data. 

The airline industry has been a major beneficiary of the vaccine euphoria. First Pfizer, then Moderna announced vaccine candidates with a promised effectiveness of 90% or more. This excited investors and airline executives alike, with visions of pent-up demand creating packed planes with filled middle seats.

Another wave of COVID-19 cases is now triggering another wave of panic buying across the country. But the Maryland Department of Commerce says it has no regulatory oversight on grocers in the state. At this point, it's up to each individual company to set purchasing limits on high-demand items. In some instances, stores are starting to see empty shelves again.

Scientists work at the mAbxience biosimilar monoclonal antibody laboratory plant in Garin, Buenos Aires province, on August 14, 2020, where an experimental coronavirus vaccine will be produced for Latin America. - Argentina will manufacture while Mexico will pack and distribute in Latin America, except of Brazil, the vaccine against COVID-19 developed by the University of Oxford and the AstraZeneca laboratory.